Results 151 to 160 of about 15,432 (213)

Differences in the Cellular Immune Response during and after Treatment of Sudanese Patients with Post-kala-azar Dermal Leishmaniasis, and Possible Implications for Outcome. [PDF]

J Epidemiol Glob Health
Torres A, Younis BM, Alamin M, Tesema S, Bernardo L, Solana JC, Moreno J, Mustafa AA, Alves F, Musa AM, Carrillo E.   +10 more
europepmc   +1 more source

A phase II, non-comparative randomised trial of two treatments involving liposomal amphotericin B and miltefosine for post-kala-azar dermal leishmaniasis in India and Bangladesh. [PDF]

PLoS Negl Trop Dis
Sundar S, Pandey K, Mondal D, Madhukar M, Kamal Topno R, Kumar A, Kumar V, Kumar Verma D, Chakravarty J, Chaubey R, Kumari P, Rashid MU, Maruf S, Ghosh P, Raja S, Rode J, den Boer M, Das P, Alvar J, Rijal S, Alves F.   +20 more
europepmc   +1 more source

Case Report: An Atypical Case of Post-Kala-Azar Dermal Leishmaniasis with Ulcers and Verrucous Lesions: Clinical and Therapeutic Implications. [PDF]

Am J Trop Med Hyg
Mathachan SR, Khurana A, Bansal A, Singhai M, Kumari R, Sardana K, Sood V, Khatri P, Singh I.   +8 more
europepmc   +1 more source

Kala azar

, 2020
openaire   +3 more sources

Infection of Leishmania donovani in Phlebotomus orientalis Sand Flies at Different Microhabitats of a Kala-Azar Endemic Village in Eastern Sudan. [PDF]

Trop Med Infect Dis
Khogali A, Elnaiem DA, Díaz-Regañón R, Jibreel T, Nour BYM, Abdelrahman SH, Molina R, Jiménez M.   +7 more
europepmc   +1 more source

Visceral leishmaniasis follow-up and treatment outcomes in Tiaty East and West sub-counties, Kenya: Cure, relapse, and Post Kala-azar Dermal Leishmaniasis. [PDF]

PLoS One
Kennedy GC, O'Brien K, Nyakundi H, Kitondo M, Biwott W, Wamai RG.   +5 more
europepmc   +1 more source

Post kala-azar dermal leishmaniasis burden at the village level in selected high visceral leishmaniasis endemic upazilas in Bangladesh.

Int J Infect Dis
Ghosh D, Sagar SK, Uddin MR, Rashid MU, Maruf S, Nath R, Islam MN, Aktaruzzaman MM, Sohel ANM, Banjara MR, Kroeger A, Aseffa A, Mondal D.   +12 more
europepmc   +1 more source

Antimony susceptible Leishmania donovani: evidence from in vitro drug susceptibility of parasites isolated from patients of post-kala-azar dermal leishmaniasis in pre- and post-miltefosine era. [PDF]

Microbiol Spectr
Ghosh S, Verma A, Kumar D, Deep DK, Ramesh V, Salotra P, Singh R.   +6 more
europepmc   +1 more source

[Kala-azar].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1991
openaire   +1 more source

A randomized double-blind Phase IIb trial to evaluate the efficacy of ChAd63-KH for the treatment of post kala-azar dermal leishmaniasis

Younis BM, Wiggins R, Khalil EA, Osman M, Santoro F, Sonnati C, Keding A, Novedrati M, Montesi G, Noureldein A, Elmukashfi ETA, Mustafa AE, Alamin M, Saeed M, Salman K, Suliman AJ, Musa AE, Layton AM, Lacey CJN, Kaye PM, Musa AM.   +20 more
europepmc   +1 more source